Hindustan Organic Chemicals Ltd
Incorporated in 1960, Hindustan Organic Chemicals Ltd is in the business of bulk industrial chemicals and chemical intermediates[1]
- Market Cap ₹ 246 Cr.
- Current Price ₹ 36.6
- High / Low ₹ 62.7 / 22.4
- Stock P/E
- Book Value ₹ 156
- Dividend Yield 0.00 %
- ROCE -5.22 %
- ROE -21.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.24 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.5% over past five years.
- Contingent liabilities of Rs.917 Cr.
- Company's cost of borrowing seems high
- Working capital days have increased from 388 days to 619 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | |
382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | |
Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 |
OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% |
6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | |
Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 |
Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 |
Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 |
Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
-202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | |
EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 7% |
TTM: | -24% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -2% |
3 Years: | % |
TTM: | -95% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 26% |
3 Years: | 8% |
1 Year: | -19% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 |
556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 206 | |
412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 313 | |
Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,564 |
151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | |
CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,333 | |
Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,564 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-13 | -116 | 46 | 59 | -451 | -160 | -81 | -50 | 10 | -13 | -66 | 631 | |
11 | 0 | -6 | -0 | 343 | 112 | 164 | 8 | 11 | 7 | 56 | 10 | |
3 | 104 | -48 | -59 | 179 | 3 | -90 | 52 | -32 | -10 | 6 | -642 | |
Net Cash Flow | -0 | -12 | -8 | 0 | 72 | -45 | -8 | 9 | -11 | -16 | -4 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 49 |
Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 21 |
Working Capital Days | -414 | -626 | -1,197 | -2,076 | 691 | 434 | 387 | 307 | 551 | 311 | 232 | 619 |
ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Results published in Newspapers are submitted.
-
Integrated Filing (Financial)
16 May - HOCL approved audited Q4 and FY25 financials; unmodified audit opinion; internal auditor re-appointed; restructuring ongoing.
- Financial Results For Q 4 And Year Ended 31.03.2025 16 May
-
Board Meeting Outcome for Outcome Of 421St Board Meeting Of HOCL
16 May - HOCL approved audited Q4 and FY25 financials with unmodified audit opinion; internal auditors re-appointed.
-
Board Meeting Intimation for 421St HOCL Board
3 May - Board meeting on 16 May to approve FY25 results and discuss share capital reduction via govt loan write-off.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from nse
Business Overview:[1][2]
HOCL was set up as a Government of India enterprise (government holds ~ 58.78% equity stake) under the administrative control of Ministry of Chemicals and Fertilizers. It is the 2nd largest producer of Phenol and Acetone
in India. Company manufactures Hydrogen Peroxide. The raw materials used by HOCL are Benzene and LPG, which come from petroleum refineries. Currently, 500+ units based on HOC’s products are setup across India. It also produces versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary viz. Hindustan Flurocarbons Limited (HFL)